Showing results (71-80 of 2,686) with videos related to

Sort By:
Pageof 269
The Lancet. Infectious Diseases|April 25, 2016
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 studyYehuda Carmeli, Jon Armstrong, Peter J Laud, et al.
The Lancet. Infectious Diseases|April 17, 2016
Aquaculture as yet another environmental gateway to the development and globalisation of antimicrobial resistanceFelipe C Cabello, Henry P Godfrey, Alejandro H Buschmann, et al.
The Lancet. Infectious Diseases|May 9, 2016
The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infantsNicholas C Grassly, Ira Praharaj, Sudhir Babji, et al.
The Lancet. Infectious Diseases|April 20, 2016
The global economic burden of dengue: a systematic analysisDonald S Shepard, Eduardo A Undurraga, Yara A Halasa, et al.
The Lancet. Infectious Diseases|February 22, 2016
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance studyGrant A Mackenzie, Philip C Hill, David J Jeffries, et al.
The Lancet. Infectious Diseases|November 26, 2015
Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort studyPatrick Nguipdop-Djomo, Einar Heldal, Laura Cunha Rodrigues, et al.
The Lancet. Infectious Diseases|February 15, 2016
The global burden of dengue: an analysis from the Global Burden of Disease Study 2013Jeffrey D Stanaway, Donald S Shepard, Eduardo A Undurraga, et al.
The Lancet. Infectious Diseases|February 17, 2016
Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Disease Study 2013Chante Karimkhani, Valentine Wanga, Luc E Coffeng, et al.
The Lancet. Infectious Diseases|July 23, 2022
Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitalsGaud Catho, Julien Sauser, Valentina Coray, et al.
The Lancet. Infectious Diseases|June 23, 2018
Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 studySumathi Sivapalasingam, Mohamed Kamal, Rabih Slim, et al.
Pageof 269